Literature DB >> 6479975

Cytologic "differentiation" in childhood rhabdomyosarcomas following polychemotherapy.

W M Molenaar, J W Oosterhuis, W A Kamps.   

Abstract

The effectiveness of polychemotherapy in young patients with rhabdomyosarcomas has been well established. The morphologic alterations in the tumor tissue, however, have not been widely reported. Therefore, in a group of 15 patients from 1 to 24 years of age, specimens of tumor tissue obtained before and after polychemotherapeutic treatment were compared. No morphologic changes, other than fibrosis and necrosis, occurred in patients who initially had virtually undifferentiated tumors. When moderately or well-differentiated areas were present in the initial specimens, these areas showed proportionate increases in the follow-up specimens. Moreover, the cellular characteristics of round rhabdomyoblasts and strap cells with or without cross-striations became more distinct after treatment. However, cell types that were not present in the initial specimens were never found in follow-up specimens. It was concluded that the major role of polychemotherapy is the selective destruction of undifferentiated tumor cells; further differentiated cells are stimulated either directly or indirectly to reach their maximal inherent differentiation levels, but it does not appear that transitions from one cell type to the other occur.

Entities:  

Mesh:

Year:  1984        PMID: 6479975     DOI: 10.1016/s0046-8177(84)80127-6

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  15 in total

1.  An analysis of histology and DNA-ploidy in primary wilms tumors and their metastases and a study of the morphological effects of therapy.

Authors:  E H van Leeuwen; A Postma; J W Oosterhuis; A Meiring; C J Cornelisse; J Koudstaal; W M Molenaar
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

2.  Multiple sites of highly amplified DNA sequences detected by molecular cytogenetic analysis in HS-RMS-2, a new pleomorphic rhabdomyosarcoma cell line.

Authors:  Eiji Takaoka; Hiroshi Sonobe; Kunihiro Akimaru; Shuji Sakamoto; Taro Shuin; Masanori Daibata; Takahiro Taguchi; Akira Tominaga
Journal:  Am J Cancer Res       Date:  2012-02-19       Impact factor: 6.166

3.  Chemotherapeutic effect on osteosarcoma on basis of collagen analysis: a proposal of the induction of osteosarcoma differentiation.

Authors:  H Tsuchiya; Y Ueda; K Tomita; I Nakanishi; A Roessner
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

4.  Influence of dimethyl sulphoxide on intermediate filament proteins in human rhabdomyosarcoma cell lines: modulation at subcellular level.

Authors:  C Melguizo; J Prados; C Velez; A E Aranega; L Alvarez; A Aranega
Journal:  Histochem J       Date:  1994-06

5.  Therapeutic cytodifferentiation in alveolar rhabdomyosarcoma without genetic change of the PAX3-FKHR chimeric fusion gene: a case study.

Authors:  Michiyuki Hakozaki; Hiroshi Hojo; Takahiro Tajino; Hitoshi Yamada; Shinichi Kikuchi; Atsushi Kikuta; Shinichi Konno; Masafumi Abe
Journal:  Hum Cell       Date:  2013-12       Impact factor: 4.174

6.  Strong immunostaining for myogenin in rhabdomyosarcoma is significantly associated with tumors of the alveolar subclass.

Authors:  P Dias; B Chen; B Dilday; H Palmer; H Hosoi; S Singh; C Wu; X Li; J Thompson; D Parham; S Qualman; P Houghton
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

7.  Cellular differentiation and prognosis in embryonal rhabdomyosarcoma. A report from the Cooperative Soft Tissue Sarcoma Study 1981 (CWS 81).

Authors:  D Schmidt; O Reimann; J Treuner; D Harms
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

8.  The in vitro growth, heterotransplantation, and differentiation of a human rhabdomyosarcoma cell line.

Authors:  A J Garvin; W S Stanley; D D Bennett; J L Sullivan; D A Sens
Journal:  Am J Pathol       Date:  1986-10       Impact factor: 4.307

9.  Expression of myogenic regulatory proteins (myogenin and MyoD1) in small blue round cell tumors of childhood.

Authors:  N P Wang; J Marx; M A McNutt; J C Rutledge; A M Gown
Journal:  Am J Pathol       Date:  1995-12       Impact factor: 4.307

10.  Expression of developmentally regulated muscle proteins in rhabdomyosarcomas.

Authors:  L C Wijnaendts; J C van der Linden; A J van Unnik; J F Delemarre; J P Barbet; G S Butler-Browne; C J Meijer
Journal:  Am J Pathol       Date:  1994-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.